低剖面支架移植物行胸主动脉腔内修复术的长期结果
该单中心回顾性分析纳入44例连续患者,评估Zenith Alpha胸主动脉支架移植物的长期结果,其中37例胸主动脉瘤、5例胸腹主动脉瘤、2例穿透性主动脉溃疡。5年持续临床成功率为84%(37/44),无支架骨折或织物撕裂,即使在高危合并症及困难髂动脉解剖患者中仍显示良好长期结果。
要点
- 5年持续临床成功率为84%(37/44),4例动脉瘤相关死亡(9%)。
- 3例I型或III型内漏,1例无内漏的动脉瘤扩张;无支架骨折或织物撕裂。
- 2例(5%)支架迁移,3例(7%)入路血管并发症,无术后神经事件。
核心结论
- 尽管为降低剖面而改变了支架移植物设计与材料,Zenith Alpha胸主动脉支架移植物在合并症多且髂动脉解剖困难的患者中仍显示良好的长期结果。
研究设计与样本
- 单中心回顾性分析,纳入2010年8月至2014年10月连续44例患者(平均年龄72.5±8.3岁,25例男性),幸存者随访至少5年。
- 治疗病变包括胸主动脉瘤37例、胸腹主动脉瘤5例、穿透性主动脉溃疡2例。
- 10例(23%)为ASA IV级,9例(20%)为非择期手术;入路血管解剖困难(平均最小直径5.4 mm,迂曲指数1.3)。
主要发现
- 5年持续临床成功率为84%(37/44),失败原因包括4例动脉瘤相关死亡(9%)、3例I型或III型内漏(其中1例为死亡患者)和1例无内漏的动脉瘤扩张。
- 3例(7%)发生入路血管并发症,无术后神经事件。
- 2例(5%)观察到支架迁移;无支架骨折或织物撕裂。
关键数值与推荐
- 5年主要终点持续临床成功定义为无动脉瘤/手术相关死亡、二次干预、I型或III型内漏、感染、血栓形成、动脉瘤扩张、破裂或转开放手术。
临床怎么用
- 对于合并症多且髂动脉解剖困难的胸主动脉疾病患者,Zenith Alpha胸主动脉支架移植物可作为腔内修复的可行选择,需注意随访内漏和支架迁移。
局限性
- 单中心回顾性设计,样本量较小(44例),结果需在更大规模前瞻性研究中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the long-term results associated with the Zenith Alpha thoracic stent-graft, which was designed to address challenging access vessel anatomy. MATERIALS AND METHODS: A retrospective analysis was conducted of 44 consecutive patients (mean age 72.5±8.3 years; 25 men) treated in a single center between August 2010 and October 2014 with a minimum follow-up of 5 years in survivors. The Zenith Alpha thoracic stent-graft was used to treat thoracic aortic aneurysms (n=37), thoracoabdominal aortic aneurysm (n=5), or penetrating aortic ulcer (n=2). Ten patients (23%) were American Society of Anesthesiologists class IV, and 9 (20%) had nonelective procedures. Access vessel anatomy was demanding (mean minimum diameter 5.4 mm, tortuosity index 1.3). The primary endpoint at 5 years was ongoing clinical success (freedom from aneurysm-/procedure-related death, secondary intervention, type I or III endoleak, infection, thrombosis, aneurysm expansion, rupture, or conversion). Secondary endpoints were freedom from all-cause mortality, device migration, stent fractures, fabric erosions, endoleaks, neurological events, and access vessel complications. RESULTS: The ongoing clinical success was 84% (37 of 44 patients) owing to 4 aneurysm-related deaths (9%), 3 type I or III endoleaks (1 in a deceased patient), and 1 aneurysm expansion without detectable endoleak. There were 3 access vessel complications (7%), and no postoperative neurological events. Migration was observed in 2 cases (5%). There were no stent fractures or fabric tears. CONCLUSION: Despite the alterations in stent-graft design and material to reduce profile, the Zenith Alpha thoracic stent-graft showed favorable long-term results even in multimorbid patients with demanding iliac anatomy.
引用
- Beropoulis E, Fazzini S, Austermann M, et al. Long-term Results of Thoracic Endovascular Aortic Repair Using a Low-Profile Stent-Graft. J Endovasc Ther. 2020. PMID: 32942922. doi:10.1177/1526602820952416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。